SELLAS Life Sciences (SLS) Shares Issued (2010 - 2026)
SELLAS Life Sciences (SLS) reported Shares Issued of $44.1 million for Q1 2026, up 91775.0% year-over-year from N/an in Q1 2025, and up 91.71% quarter-over-quarter from $23.0 million in Q3 2025.
SELLAS Life Sciences (SLS) Shares Issued (2010 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has 17 years of Shares Issued data on file, last reported at $44.1 million in Q1 2026.
- Shares Issued for Q1 2026 came in at $44.1 million, up 91775.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $67.1 million (up 70534.74% YoY), and the FY2025 annual result was $23.1 million, up 23421.43% from the prior year.
- Shares Issued improved to $44.1 million in Q1 2026 per SLS's latest filing, from $23.0 million in the prior quarter.
- Over five years, Shares Issued peaked at $44.1 million in Q1 2026 and troughed at -$93000.0 in Q4 2023.
- A 5-year average of $6.1 million and a median of $48000.0 in 2025 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2022 and 2026: Shares Issued tumbled 98.74% in 2022, then surged 91775.0% in 2026.
- A 5-year view of Shares Issued shows it stood at -$85000.0 in 2022, then slipped by 9.41% to -$93000.0 in 2023, then soared by 150.54% to $47000.0 in 2024, then jumped by 48842.55% to $23.0 million in 2025, then surged by 91.71% to $44.1 million in 2026.
- Business Quant data shows SLS's Shares Issued at $44.1 million in Q1 2026, $23.0 million in Q3 2025, and $48000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26,927.15 |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | 44.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.10 Mn |
| Mar 31, 2026 | 44.10 Mn |
| Sep 30, 2025 | 23.00 Mn |
| Sep 30, 2025 | 23.00 Mn |
| Mar 31, 2025 | 48,000.00 |
| Mar 31, 2025 | 48,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | -93,000.00 |
| Dec 31, 2023 | -93,000.00 |
| Sep 30, 2023 | 54,000.00 |
| Sep 30, 2023 | 54,000.00 |
| Jun 30, 2023 | 268,000.00 |
| Jun 30, 2023 | 268,000.00 |
| Dec 31, 2022 | -85,000.00 |
| Dec 31, 2022 | -85,000.00 |
| Sep 30, 2022 | 38,000.00 |
| Sep 30, 2022 | 38,000.00 |